Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management
- PMID: 33893638
- DOI: 10.1111/jgs.17142
Frailty and cognitive impairment are not reasons to withhold anticoagulation in people with atrial fibrillation but screening could guide management
Comment on
-
Frailty, Cognitive Impairment, and Anticoagulation Among Older Adults with Nonvalvular Atrial Fibrillation.J Am Geriatr Soc. 2020 Dec;68(12):2778-2786. doi: 10.1111/jgs.16756. Epub 2020 Aug 11. J Am Geriatr Soc. 2020. PMID: 32780497 Free PMC article.
References
REFERENCES
-
- Lip GYH, Banerjee A, Boriani G, et al. Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report. Chest. 2018;154:1121-1201.
-
- Lip GY, Skjøth F, Nielsen PB, Larsen TB. Non-valvular atrial fibrillation patients with none or one additional risk factor of the CHA2DS2-VASc score. A comprehensive net clinical benefit analysis for warfarin, aspirin, or no therapy. Thromb Haemost. 2015;114:826-834.
-
- Aronson D, Shalev V, Katz R, Chodick G, Mutlak D. Risk score for prediction of 10-year atrial fibrillation: a community-based study. Thromb Haemost. 2018;118:1556-1563.
-
- Borre ED, Goode A, Raitz G, et al. Predicting thromboembolic and bleeding event risk in patients with non-valvular atrial fibrillation: a systematic review. Thromb Haemost. 2018;118:2171-2187.
-
- Fauchier L, Bodin A, Bisson A, et al. Incident comorbidities, aging and the risk of stroke in 608,108 patients with atrial fibrillation: a nationwide analysis. J Clin Med. 2020;9(4):1234.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical